ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $210,000 | -0.9% | 3,375 | +8.0% | 0.00% | 0.0% |
| Q1 2017 | $212,000 | -12.0% | 3,125 | -8.8% | 0.00% | 0.0% |
| Q4 2016 | $241,000 | -74.3% | 3,425 | -74.1% | 0.00% | -72.7% |
| Q3 2016 | $936,000 | -42.7% | 13,200 | -60.5% | 0.01% | +10.0% |
| Q2 2016 | $1,634,000 | +59.3% | 33,400 | +106.2% | 0.01% | -28.6% |
| Q1 2016 | $1,026,000 | -44.1% | 16,200 | -0.9% | 0.01% | -44.0% |
| Q4 2015 | $1,834,000 | +73.2% | 16,350 | +48.6% | 0.02% | +78.6% |
| Q3 2015 | $1,059,000 | – | 11,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |